Back
Biodesix, Inc. 10K Form
Buy
51
BDSX
Biodesix, Inc.
Last Price:
$8.54
Seasonality Move:
-7.16%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-03-16 | 10K | BDSX/Biodesix, Inc. Annual |
| 2020-12-10 | 10Q | BDSX/Biodesix, Inc. Quarterly |
Receive BDSX News And Ratings
See the #1 stock for the next 7 days that we like better than BDSX
BDSX Financial Statistics
Sales & Book Value
| Annual Sales: | $71.3M |
|---|---|
| Cash Flow: | $-8.9M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.22 |
| Price / Book: | 53.43 |
Profitability
| EPS (TTM): | -3.92750 |
|---|---|
| Net Income (TTM): | $-39.5M |
| Gross Margin: | $50.4M |
| Return on Equity: | -333.87% |
| Return on Assets: | -42.55% |
Biodesix, Inc. Earnings Forecast
Key Biodesix, Inc. Financial Ratios
-
The Gross Profit Margin over the past 7 years for BDSX is 70.65%.
-
The Selling, General & Administrative Expenses for BDSX have been equal to 112.80% of Gross Profit Margin.
-
The Research & Development expenses have been 13.40% of Revenue.
-
The Net Earning history of BDSX is -60.19% of Total Revenues.
-
Per Share Earnings over the last 7 years have been positive in 3 years.
Biodesix, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Providers & Services |
| Sector: | Health Care |
| Current Symbol: | BDSX |
| CUSIP: | 09075X |
| Website: | biodesix.com |
Debt
| Debt-to-Equity Ratio: | -42.35 |
|---|---|
| Current Ratio: | 1.84 |
| Quick Ratio: | 1.62 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BDSX Technical Analysis vs Fundamental Analysis
Buy
51
Biodesix, Inc. (BDSX)
is a Buy
Is Biodesix, Inc. a Buy or a Sell?
-
Biodesix, Inc. stock is rated a BuyThe current Biodesix, Inc. [BDSX] share price is $8.14. The Score for BDSX is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.